GVP Module III: Pharmacovigilance Inspections

The issue is limited to an outdated document and has no operational significance The discrepancy may indicate a control failure and broader governance weakness The practice is acceptable because quarterly reconciliation is always sufficient The issue can be resolved by changing the SOP during the inspection

The QPPV should personally answer every operational question The QPPV should explain the overall system and demonstrate awareness of significant risks and weaknesses while operational experts address detailed processes The QPPV's role is limited to attending the opening and closing meetings The QPPV should delegate all inspection matters to the quality department

Backdate the missing records so the historical file appears complete Create replacement evidence using the current process and present it as contemporaneous Document the facts, assess impact, implement proportionate containment or corrective action and preserve chronology Remove the affected period from the inspection materials

Triggered inspections are automatically required to examine every pharmacovigilance activity Inspectors may identify additional systemic concerns while examining the initial issue The MAH must voluntarily add unrelated processes to the inspection scope Only routine inspections are permitted to remain within their original scope

Ignore the finding until the authority withdraws it Argue that the issue is minor without providing supporting evidence Identify the disputed fact or interpretation, cite the applicable requirement and provide precise evidence while still assessing safety and system implications Change the relevant records to align them with the preferred interpretation

A visually polished spreadsheet with no technical description A large volume of data supplied without filters or exclusions A reproducible derivation with documented population, fields, filters, dates, time zones and transformations A manually edited extract that removes records considered irrelevant

To coach witnesses to provide uniform answers To coordinate requests, deadlines and escalation while preserving factual and access-controlled notes To negotiate the classification of findings before evidence collection is complete To suspend routine pharmacovigilance activities until the inspection ends

Module III contains all substantive requirements for every pharmacovigilance activity Module III provides the inspection framework, while the standards inspected are distributed across legislation, GVP modules and product-specific obligations Other GVP modules apply only after an inspection finding has been classified Module III eliminates the need to consult national procedures or Union procedures

Averages are never accepted as quality information A strong average can conceal overdue or otherwise high-risk individual items and important exceptions Metrics are relevant only to clinical trials Average metrics automatically prove that the PSMF is inaccurate

To rank inspectors according to the difficulty of their questions To document requests, owners, clarifications, materials supplied and transmission timing To replace quality review of submitted documents To record only requests that the MAH can answer immediately